“…Then, 10 mice were randomly assigned to a sham group, and the rest of the 30 mice were used to establish the AKI model and randomly assigned to 3 groups ( N = 10), which are ischemia/reperfusion (I/R) group (30 min of bilateral ischemia), sh-NC group (injected slowly with a total volume of 20 μl sh-NC adenovirus with a titer of 1 × 10 7 particles/μl via the caudal vein using a 4-gauge needle 1 week before I/R treatment), and sh-Kcnq1ot1 group (injected with 20 μl sh-Kcnq1ot1 adenovirus with 1 × 10 7 particles/μl via the caudal vein 1 week before I/R treatment). The sh-Kcnq1ot1 or sh-NC (sh-Kcnq1ot1 sequence: 5′-GCAGAACCAUCGAUGGUGCGU-3′; sh-NC: 5′-AGUGCUGCGCACGUGUCUCAU-3′; RiboBio, Beijing, China) was introduced into the adenoviral vector (Life Technologies, Shanghai, China) to form adenovirus solution of sh-Kcnq1ot1 or sh-NC by using Gateway TM LR Clonase II Enzyme Mix (Invitrogen, Carlsbad, CA, United States) ( Xue et al, 2021 ). Mice were intraperitoneally injected with pentobarbital sodium (60 mg/kg; Sigma-Aldrich, St. Louis, MO, United States) to ensure that mice were fully anesthetized before the surgery and a heating pad was used to maintain the body temperature of mice.…”